0001214659-20-003820.txt : 20200428 0001214659-20-003820.hdr.sgml : 20200428 20200428163328 ACCESSION NUMBER: 0001214659-20-003820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200424 FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kazam Joshua A CENTRAL INDEX KEY: 0001221355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 20825589 MAIL ADDRESS: STREET 1: 689 5TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHUA A DATE OF NAME CHANGE: 20070920 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHOA A DATE OF NAME CHANGE: 20030303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-48642.xml PRIMARY DOCUMENT X0306 4 2020-04-24 0001737287 Allogene Therapeutics, Inc. ALLO 0001221355 Kazam Joshua A 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false Common Stock 2020-04-24 4 J false 8039 0.00 A 1023336 D Pro rata distribution of shares of the Issuer's common stock from VVAG LLC to its members. /s/ Veer Bhavnagri, Attorney-in-Fact 2020-04-28